Savara (SVRA) Payables (2010 - 2026)
Savara (SVRA) reported Payables of $4.5 million for Q1 2026, down 19.09% year-over-year from $5.6 million in Q1 2025, and down 21.9% quarter-over-quarter from $5.8 million in Q4 2025.
Savara (SVRA) Payables (2010 - 2026) Analysis & Trends
Savara (SVRA) has 17 years of Payables data on file, last reported at $4.5 million in Q1 2026.
- Payables for Q1 2026 came in at $4.5 million, down 19.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.5 million (down 19.09% YoY), and the FY2025 annual result was $5.8 million, up 26.67% from the prior year.
- Payables declined to $4.5 million in Q1 2026 per SVRA's latest filing, from $5.8 million in the prior quarter.
- Over five years, Payables peaked at $5.8 million in Q4 2025 and troughed at $805000.0 in Q2 2022.
- A 5-year average of $3.2 million and a median of $3.4 million in 2024 frame the typical range for Payables.
- The sharpest annual moves came in 2022 and 2023: Payables tumbled 62.45% in 2022, then surged 260.47% in 2023.
- A 5-year view of Payables shows it stood at $1.3 million in 2022, then soared by 162.67% to $3.5 million in 2023, then advanced by 29.71% to $4.5 million in 2024, then grew by 26.67% to $5.8 million in 2025, then retreated by 21.9% to $4.5 million in 2026.
- Business Quant data shows SVRA's Payables at $4.5 million in Q1 2026, $5.8 million in Q4 2025, and $4.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.69 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Savara | 1.39 Bn | 1.39 Bn | - | 4.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.50 Mn |
| Dec 31, 2025 | 5.76 Mn |
| Sep 30, 2025 | 4.14 Mn |
| Jun 30, 2025 | 4.75 Mn |
| Mar 31, 2025 | 5.56 Mn |
| Dec 31, 2024 | 4.55 Mn |
| Sep 30, 2024 | 4.61 Mn |
| Jun 30, 2024 | 3.39 Mn |
| Mar 31, 2024 | 2.85 Mn |
| Dec 31, 2023 | 3.50 Mn |
| Sep 30, 2023 | 3.22 Mn |
| Jun 30, 2023 | 2.50 Mn |
| Mar 31, 2023 | 1.57 Mn |
| Dec 31, 2022 | 1.33 Mn |
| Sep 30, 2022 | 893,000.00 |
| Jun 30, 2022 | 805,000.00 |
| Mar 31, 2022 | 1.30 Mn |
| Dec 31, 2021 | 1.44 Mn |
| Sep 30, 2021 | 1.28 Mn |
| Jun 30, 2021 | 2.14 Mn |